Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Problems in serum-level determination during valproic acid therapy].

H Schäfer, H Reith, R Jacobs

    Arzneimittel-Forschung
    |January 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Advanced platform for the in-plane ZT measurement of thin films.

    The Review of scientific instruments·2018
    Same author

    The experimental investigation of thermal conductivity and the Wiedemann-Franz law for single metallic nanowires.

    Nanotechnology·2009
    Same author

    Notch1 activation reduces proliferation in the multipotent hematopoietic progenitor cell line FDCP-mix through a p53-dependent pathway but Notch1 effects on myeloid and erythroid differentiation are independent of p53.

    Cell death and differentiation·2007
    Same author

    Monoclonal antibodies to guinea pig interferon-gamma: tools for cytokine detection and neutralization.

    Journal of immunological methods·2007
    Same author

    Characterisation and expression of monosaccharide transporters in lupins, Lupinus polyphyllus and L. albus.

    Journal of plant research·2007
    Same author

    The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.

    Oncogene·2007
    Same journal

    Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Kapuzinerkressenkraut und Meerrettich bei akuter Sinusitis, akuter Bronchitis und akuter Blasenentzündung im Vergleich zu anderen Therapien unter den Bedingungen der täglichen Praxis.

    Arzneimittel-Forschung·2013
    Same journal

    Abstracts of the Paul-Martini-Stiftung Symposium 2012 in combination with the National Academy of Leopoldina. November 16-17, 2012. Berlin, Germany.

    Arzneimittel-Forschung·2013
    Same journal

    Leave-one-out procedure in the validation of elimination rate constant analysis.

    Arzneimittel-Forschung·2012
    Same journal

    Pharmacokinetic and myocardial enzyme profiles of two administration routes of epirubicin in breast cancer patients.

    Arzneimittel-Forschung·2012
    Same journal

    Synthesis, anti-hypertensive effect of a novel angiotensin II AT1 receptor antagonist and its anti-tumor activity in prostate cancer.

    Arzneimittel-Forschung·2012
    Same journal

    Effect of zeolite nano-materials and artichoke (Cynara scolymus L.) leaf extract on increase in urinary clearance of systematically absorbed nicotine.

    Arzneimittel-Forschung·2012
    See all related articles

    Achieving a stable serum level of valproic acid for epilepsy treatment is challenging. This study found inconsistent drug concentrations, questioning the reliability of single measurements for therapeutic control.

    Area of Science:

    • Pharmacokinetics
    • Clinical Pharmacy
    • Neurology

    Background:

    • Valproic acid is a widely used anticonvulsant for epilepsy management.
    • Therapeutic drug monitoring aims to optimize treatment efficacy and minimize toxicity.
    • Establishing reliable serum levels is crucial for effective patient management.

    Purpose of the Study:

    • To investigate the reproducibility of steady-state serum valproic acid concentrations.
    • To determine if single serum level measurements are sufficient for therapeutic control in epilepsy patients.

    Main Methods:

    • Long-term (8-week) monitoring of serum valproic acid levels in 11 patients.
    • 24-hour serum concentration profiling in 8 patients under monotherapy and combined therapy.
    • Analysis of drug half-life and time to maximum concentration.

    Related Experiment Videos

    Main Results:

    • No reliable and comparable steady-state serum valproic acid concentrations were achieved in 11 patients over 8 weeks.
    • Inconsistent 24-hour serum profiles were observed in 8 patients.
    • Valproic acid half-life ranged from 8 to 12.5 hours, with unpredictable peak concentration times.
    • Morning fasting values showed limited comparability.

    Conclusions:

    • Single serum valproic acid measurements may not be reliable for therapeutic control in epilepsy.
    • Further investigation into daily profiles is needed to assess the utility of serum concentration monitoring for individual patient treatment.